Nymox Pharmaceutical Corporation total revenue, net income and dynamics of changes in US dollar today
The dynamics of Nymox Pharmaceutical Corporation net revenue increased by 0 $ from the last reporting period. Net income of Nymox Pharmaceutical Corporation today amounted to -2 439 000 $. The dynamics of net income of Nymox Pharmaceutical Corporation has changed by -412 000 $ in recent years. Graph of the financial report of Nymox Pharmaceutical Corporation. The financial graph of Nymox Pharmaceutical Corporation shows the values and changes of such indicators: total assets, net income, net revenue. The financial report schedule from 30/06/2017 to 31/03/2021 is available online.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Nymox Pharmaceutical Corporation financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Nymox Pharmaceutical Corporation for today is 31/03/2021. Operating income Nymox Pharmaceutical Corporation is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Nymox Pharmaceutical Corporation is -2 429 000 $
Net income Nymox Pharmaceutical Corporation is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Nymox Pharmaceutical Corporation is -2 439 000 $ Current assets Nymox Pharmaceutical Corporation is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Nymox Pharmaceutical Corporation is 1 061 000 $ Total assets Nymox Pharmaceutical Corporation refers to the total amount of assets owned by a person or entity. Total assets Nymox Pharmaceutical Corporation is 1 455 000 $
Current cash Nymox Pharmaceutical Corporation - the sum of all of the cash a company has on the date of report. Current cash Nymox Pharmaceutical Corporation is 880 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
1 000 $
-10 000 $
15 000 $
64 000 $
93 000 $
60 783 $
-1 820 $
-17 177 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
29 000 $
29 000 $
25 000 $
24 000 $
59 000 $
44 513 $
32 698 $
26 609 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
30 000 $
19 000 $
40 000 $
88 000 $
152 000 $
105 296 $
30 878 $
9 432 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
30 000 $
19 000 $
40 000 $
88 000 $
152 000 $
105 296 $
30 878 $
9 432 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 429 000 $
-2 015 000 $
-4 144 000 $
-2 932 000 $
-2 923 000 $
-2 753 000 $
-2 810 000 $
-2 420 000 $
-2 658 000 $
-3 309 052 $
-4 566 560 $
-2 597 155 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 439 000 $
-2 027 000 $
-4 156 000 $
-2 940 000 $
-2 870 000 $
-2 720 000 $
-2 791 000 $
-2 419 000 $
-2 664 000 $
-3 328 122 $
-4 581 822 $
-2 705 353 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 425 000 $
1 174 000 $
3 235 000 $
2 156 000 $
1 729 000 $
1 720 000 $
1 654 000 $
1 549 000 $
1 957 000 $
2 460 111 $
2 152 408 $
1 585 140 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 429 000 $
2 015 000 $
4 144 000 $
2 932 000 $
2 953 000 $
2 772 000 $
2 850 000 $
2 508 000 $
2 751 000 $
3 369 835 $
4 564 740 $
2 579 978 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 061 000 $
3 893 000 $
5 633 000 $
886 000 $
11 423 000 $
8 026 000 $
4 751 000 $
5 148 000 $
936 000 $
961 000 $
1 784 014 $
1 304 785 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 455 000 $
4 343 000 $
5 740 000 $
1 055 000 $
11 800 000 $
8 076 000 $
4 779 000 $
5 166 000 $
954 000 $
979 000 $
1 802 295 $
1 323 354 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
880 000 $
3 611 000 $
5 365 000 $
767 000 $
11 293 000 $
7 946 000 $
4 658 000 $
5 040 000 $
850 000 $
851 000 $
1 738 907 $
1 264 489 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
1 429 000 $
1 074 000 $
849 000 $
1 615 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
850 000 $
851 000 $
1 738 907 $
1 264 489 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 711 000 $
1 074 000 $
849 000 $
1 615 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
14.50 %
13.30 %
17.77 %
31.26 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-12 000 $
2 145 000 $
3 844 000 $
-1 064 000 $
10 089 000 $
7 002 000 $
3 930 000 $
3 551 000 $
-1 044 000 $
-1 251 000 $
8 923 $
-718 580 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-1 593 000 $
-1 687 000 $
-2 371 000 $
-1 910 000 $
-1 833 000 $
-1 269 046 $
-2 427 601 $
-1 769 353 $
Last revenue report of Nymox Pharmaceutical Corporation was 31/03/2021. According to last financial report total revenue in Nymox Pharmaceutical Corporation was 0 US dollar and changed by -100% since last year. Net income in Nymox Pharmaceutical Corporation was -2 439 000 $ in last quartal, net income changes to 0%.
